Company intelligence / Profile preview

Endo Tools Therapeutics

Gosselies, Wallonia, Belgiumendotools.be ↗

Ownership: Private
Employees: ~22
Development stage: Commercial

Overview

The company’s lead product, the endomina system, has CE mark approval for endoscopic gastroplasty and FDA clearance for tissue approximation. The procedure has been performed on more than 500 patients in Europe. Clinical results indicate that the device enables minimally invasive gastric interventions with improved patient outcomes compared to traditional surgical approaches.

Therapeutic areas: GastroenterologyEndocrinology
Modalities: DeviceNon-pharmacological therapy (incisionless endoscopic surgery)
Industry: Surgical Medical Devices

Drug pipeline

1 asset

endomina

Commercial

Indications: Obesity, Gastroesophageal reflux disease

Beyond the preview

Go deeper on Endo Tools Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Endo Tools Therapeutics.

Explore the full profile